Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Haiyan Pharmaceutical is a core subsidiary of the Yangtze River Pharmaceutical Group (YRPG), located in the Zhongguancun Life Science Park in Beijing. Established in 2004, the company serves as a critical hub for the research, development, and manufacturing of high-quality chemical pharmaceuticals. Its product portfolio is particularly strong in gastroenterology, cardiovascular health, and anti-infectives, featuring widely prescribed medications like esomeprazole and rosuvastatin. The company operates advanced manufacturing facilities that adhere to stringent international GMP standards, supporting YRPG's position as a leader in the Chinese pharmaceutical market. Beijing Haiyan is increasingly focused on transitioning from high-end generics to the development of innovative small molecule drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Haiyan Pharmaceutical Industry.